Skip to main content
SCYNEXIS INC logo

SCYNEXIS INC — Investor Relations & Filings

Ticker · SCYX ISIN · US8112922005 LEI · 529900XBHFGMNTU70154 US Manufacturing
Filings indexed 684 across all filing types
Latest filing 2016-05-09 Interim / Quarterly Rep…
Country US United States of America
Listing US SCYX

About SCYNEXIS INC

https://www.scynexis.com/

SCYNEXIS, Inc. is a biotechnology company focused on the discovery and development of novel anti-infectives to overcome difficult-to-treat and drug-resistant fungal infections. The company is pioneering a new class of broad-spectrum antifungal agents called 'fungerps,' which are triterpenoid-based compounds. These agents are being developed in both oral and intravenous formulations to treat a range of serious, invasive, and life-threatening fungal diseases, particularly those encountered in hospital environments. SCYNEXIS aims to address the significant global health threat of antifungal resistance by providing innovative therapeutic options where existing treatments are limited or ineffective. The company's development pipeline includes second-generation fungerp candidates.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q1 2016
2016-05-09 English
DEFINITIVE ADDITIONAL MATERIALS
Proxy Solicitation & Information Statement Classification · 95% confidence The document is titled 'Definitive Additional Materials' and is a Schedule 14A filing, which is a proxy statement related to shareholder voting matters. It references the Annual Meeting of Stockholders, lists nominees for the board of directors, and includes voting instructions. It also mentions the proxy materials and the annual report availability but does not contain the full annual report or detailed financial data itself. The document is 4271 characters long, which is relatively short and consistent with proxy solicitation materials. Therefore, this document is best classified as Proxy Solicitation & Information Statement (PSI).
2016-04-21 English
DEF 14A
Proxy Solicitation & Information Statement
2016-04-21 English
424B5
Capital/Financing Update Classification · 95% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(5) related to a controlled equity offering of common stock. It includes detailed information about the terms of the offering, the sales agreement with Cantor Fitzgerald, risk factors, use of proceeds, dilution, plan of distribution, and legal matters. The document is not a financial report, earnings release, or management discussion but rather a capital raising disclosure document. It is a detailed offering document related to financing activities and capital structure changes. Therefore, it fits the category of Capital/Financing Update (CAP). The document length and content confirm it is not a brief announcement or a regulatory filing fallback. Confidence is high due to the clear nature of the document as a prospectus supplement for a stock offering.
2016-04-11 English
FORM 8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the termination of a previous sales agreement and the entry into a new Controlled Equity Offering Sales Agreement for an ATM offering of common stock. It includes details about the terms of the sales agreement, compensation, and legal opinions attached as exhibits. There are no financial statements or comprehensive financial data presented, nor is this an earnings release or annual/interim report. The document is an announcement of financing activity related to capital raising through equity sales. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is sufficient and contains substantive information about the financing event, not just a brief notice or report publication announcement.
2016-04-11 English
FORM 3/A
Director's Dealing
2016-04-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.